ID Biomedical elects to sell surplus vaccine to Canada, not the U.S.

MONTREAL (CP) - ID Biomedical, Canada's main supplier of flu vaccine, has elected to sell its remaining surplus doses of vaccine in Canada, not the United States, the company announced Tuesday. Chief Executive Officer Dr....More